HIGHLIGHTS
- who: Scoparone Improves NASH and collaborators from the Beijing University of Chinese Medicine, China have published the article: Scoparone Improves Nonalcoholic Steatohepatitis Through Alleviating JNK/Sab Signaling Pathway-Mediated Mitochondrial Dysfunction, in the Journal: (JOURNAL)
- what: The accumulation of fatty_acids activates JNK/Sab signaling pathway to induce mitochondrial dysfunction, promoting May 2022 | Volume 13 | Article 863756 Scoparone Improves NASH
- how: Western blot results showed that PA increased the expression of cleaved PARP of scramble HepG2 cells significantly while the Sab-knockdown cells had a lower expression suggesting that lipid-induced apoptosis had been . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.